EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

COTRIMAZIN Bioveta 288.2/58.0 mg/g oral paste Trimethoprimum, sulfadiazinum

Homepage Products Veterinary products COTRIMAZIN Bioveta 288.2/58.0 mg/g oral paste Trimethoprimum, sulfadiazinum

A broad-spectrum product with excellent bactericidal activity effective against the most common causes of infections in horses,

type of preparative: Antimicrobial products
target species animals: Horse

Can we help you?

Content

Active substances:

1 g of paste contains:

Sulfadiazinum             288.2 mg
Trimethoprimum         58.0 mg

Oral paste. White to light brown oral paste.

TARGET SPECIES

Horses.

INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES

Treatment of bacterial infections in horses (infections of the digestive tract - diarrhoea, respiratory tract infections - pneumonia, pleurisy, strangulation, wound infections, septicaemia, and systemic infections) caused by microorganisms sensitive to the combination of active substances:
Rhodococcus equi
Staphylococcus spp.
Streptococcus
spp.
Escherichia coli

CONTRAINDICATIONS

Do not use in case of hypersensitivity to the active substance(s) or any of the excipients.

SPECIAL WARNINGS FOR EACH TARGET SPECIES

Do not use the applicator for more than one animal. Do not feed animals for a few hours prior to administration; reducing content in the gastrointestinal tract ensures better systemic absorption of the active substances.

USE DURING PREGNANCY AND LACTATION

Administration of this combination of active substances during pregnancy, especially in the early stages, can lead to congenital defects in foals. Use of the product during pregnancy should be based on a consideration of risks versus benefits by the attending veterinarian. Sulfonamides pass into maternal milk and may have a negative effect on foals suckling from sulfonamide treated mares. Use of the product during lactation should be based on a consideration of risks versus benefits by the attending veterinarian.

AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE

Oral administration. The recommended dose is 30 mg of combined active substances/kg bodyweight/day. The contents of 1 applicator is sufficient for 1 daily dose for a horse weighing up to 600 kg.Administer the product 1x a day for a period of 5 days, or 2 more days after symptoms have disappeared. To ensure the correct dose, the horse’s weight should be determined as accurately as possible and the accuracy of the dosing regimen checked.

Use of the dispensing applicator:
The applicator should be adjusted to the calculated dose by setting the ring to the appropriate mark on the plunger. The plunger is calibrated, one marking corresponds to a dose for 50 kg of bodyweight. The calculated dose is provided by adjusting the ring on the plunger according to the bodyweight of the horse. Before administering, make sure the horse’s mouth is free of any food. Remove the cap from the applicator, insert in the horse’s mouth through the interdental space and deposit the required amount of paste on the back of the tongue. Immediately after administration, elevate the horse’s head for a few seconds to ensure the dose is swallowed. After administering, place the cap back on the applicator.

WITHDRAWAL PERIODS

Do not use on horses whose meat is intended for human consumption. Do not use on horses whose milk is intended for human consumption.

SHELF LIFE

Shelf life of the veterinary medicinal product as packaged for sale: 2 years. Shelf life after first opening of immediate packaging: 6 months.

SPECIAL PRECAUTIONS FOR STORAGE

Do not refrigerate or freeze.  Store in the original packaging.

PACKAGE SIZES

1 × 54 g, 5 × 54 g.

Not all pack sizes may be marketed.